Peptide Bionanomaterials: From Design to Application
暫譯: 肽生物奈米材料：從設計到應用

Dr Mohamed Elsawy is a Senior Lecturer in Pharmaceutical Sciences at the Leicester School of Pharmacy, De Montfort University and the team leader of the Peptide BioNanomaterials Group (PBNG). He obtained his PhD from School of Pharmacy at Queen's University of Belfast in 2012 followed by a short-term fellowship at University of Bordeaux in 2013 and an EPSRC funded postdoctoral training in University of Manchester between 2014-2017. In 2017, he was appointed a lectureship in Pharmaceutics at the School of Pharmacy and Biomedical Sciences, University of Central Lancashire, then in 2020 he moved to the Leicester Institute for Pharmaceutical Innovation at Leicester School of Pharmacy, where he currently works. Dr Elsawy's research focus on understanding the fundamentals of peptide self-assembly into bio-inspired structures for the design of stable and responsive functional bionanomaterials for various biomedical and pharmaceutical applications, with particular interest in drug delivery and tissue engineering. Together with the rational bottom-up molecular design of peptide nanostructures, his group is currently working towards exploitation of various smart manufacturing technologies for the controlled design and fabrication of these materials.

穆罕默德·艾爾薩維博士（Dr Mohamed Elsawy）是德蒙福特大學萊斯特藥學院（Leicester School of Pharmacy）藥學科的高級講師，並且是肽生物奈米材料小組（Peptide BioNanomaterials Group, PBNG）的團隊負責人。他於2012年在貝爾法斯特女王大學（Queen's University of Belfast）的藥學院獲得博士學位，隨後於2013年在波爾多大學（University of Bordeaux）進行短期研究獎學金，並於2014年至2017年間在曼徹斯特大學（University of Manchester）接受EPSRC資助的博士後訓練。2017年，他被任命為中央蘭開夏大學（University of Central Lancashire）藥學與生物醫學科學學院的藥劑學講師，然後在2020年轉至萊斯特藥學院的萊斯特藥物創新研究所（Leicester Institute for Pharmaceutical Innovation），目前在此工作。艾爾薩維博士的研究重點在於理解肽自組裝成生物啟發結構的基本原理，以設計穩定且具反應性的功能性生物奈米材料，應用於各種生物醫學和藥學領域，特別關注藥物傳遞和組織工程。除了理性自下而上的肽奈米結構分子設計外，他的團隊目前也在致力於利用各種智能製造技術，進行這些材料的受控設計和製造。